Jan 12, 2021 / 03:00PM GMT
Tycho W. Peterson - JPMorgan Chase & Co, Research Division - Senior Analyst
Okay. Good morning. We're going to kick it off. I'm Tycho Peterson from the Life Science team. It's my pleasure to introduce our next company this morning, Charles River Labs. For those that have questions, please submit through the website.
And with that, I'll turn it over to Jim.
James C. Foster - Charles River Laboratories International, Inc. - Chairman, CEO & President
Thanks, Tycho. It's always a pleasure to be at JPMorgan, albeit virtually this year. So I would point you to our safe harbor statement, Reg G statement. And of course, we are in a quiet period. So we've had a lot of first and some significant milestones in the company. We worked on more than 80% of the drugs that were approved over the last 3 years. We've doubled the revenue of the company over the last 5. We're working at about a $15 billion market. So it gives us a lot of leeway and runway to grow our business in the current markets that we're in. We have a market leadership position in many of the
Charles River Laboratories International Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers